SenesTech (NASDAQ:SNES) Research Coverage Started at StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of SenesTech (NASDAQ:SNES) in a research note issued on Thursday. The firm set a “sell” rating on the stock.

SenesTech Stock Performance

Shares of SNES stock opened at $0.84 on Thursday. The company has a debt-to-equity ratio of 0.02, a quick ratio of 7.48 and a current ratio of 8.49. The company’s fifty day moving average price is $0.77 and its 200-day moving average price is $1.27. SenesTech has a 12 month low of $0.52 and a 12 month high of $17.52.

Institutional Trading of SenesTech

A hedge fund recently bought a new stake in SenesTech stock. Armistice Capital LLC purchased a new position in SenesTech, Inc. (NASDAQ:SNES) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 70,425 shares of the company’s stock, valued at approximately $30,000. Armistice Capital LLC owned approximately 1.94% of SenesTech at the end of the most recent reporting period. 5.19% of the stock is currently owned by hedge funds and other institutional investors.

About SenesTech

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.